Wednesday, December 23, 2020

Commentaries, Analysis, And Editorials -- December 23, 2020

 


At least four drug makers are rushing to confirm the efficacy of their COVID-19 vaccines against the new fast-spreading variant of the virus detected in the UK. 

The mutation known as the B.1.1.7 lineage may be up to 70 per cent more infectious and more of a concern for children. 

Moderna, Germany's CureVac, and Britain's AstraZeneca believe their shots, which target the virus that causes COVID-19 — SARS-CoV-2 — will also work against the new strain that has sown chaos in the UK. 

Read more .... 

 Commentaries, Analysis, And Editorials -- December 23, 2020 

No need for panic over UK’s new virus strain -- Jonathan Gornall, Asia Times 





As crisis looms, Lebanon’s staple becomes a luxury -- Hussain Abdul-Hussain, Asia Times 


Time to Make the Taliban Diplomatically Uncomfortable -- Jason Criss Howk, Clearance Jobs 

Three Challenges Biden Must Confront -- Yoichi Funabashi, National Interest 



Vietnam's Sole Military -- Ally Khang Vu, The Diplomat 

A tale of two Europes -- Craig Kennedy and Gary Schmitt, The Hill 

Three Articles Signal New Cold War -- Francis P. Sempa, RCD 


No comments: